HYPHENS PHARMA INTERNATIONAL LIMITED

1J5/SI
Revenue Growth
-
Profit Growth
-
Net Margin
-
ROE
-
Financials
Announcements
Dividends
Buybacks
Corp Actions
Revenue & Profit
Financial Data
Date Type Period Title Sentiment
Dividend History
DateTypeAmountCurrencyEx-DatePayment Date
Buyback Activity
DateSharesAvg PriceTotal ($)Cumulative
DateTypeDetails

HYPHENS PHARMA INTERNATIONAL LIMITED (1J5/SI) — FY2025: Revenue SGD 177M, Profit 6M, EPS 1.97. Data: FY2015-FY2025, Q1, Q2, Q3, Q4 quarterly data.

Historical Annual Data (11 years)
FYRevenue (M)Net Profit (M)EPSTotal Assets (M)Total Equity (M)
FY202517761.9712473
FY2024195113.313674
FY202317192.7712166
FY2022162113.6811470
FY202112672.26--

Compare 1J5 with

vs Singtel vs Wilmar vs DBS vs SIA vs UOB vs QAF vs Micro-Mechanics vs UOL